JKJörg Kempfert

Jörg Kempfert

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jörg Kempfert has a total of 302 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Minimally Invasive Mitral Valve Surgery: Current Evidence and Best Practice Models

    by Serdar Akansel, Markus Kofler, Joerg Kempfert, Volkmar Falk

    Objective: Minimally invasive mitral valve surgery (MI-MVS) has evolved into a widely adopted surgical strategy for the treatment of mitral valve (MV) disease. This narrative review summarizes, the importance of preoperative diagnostic work-ups, contemporary surgical techniques, perioperative management, learning curve considerations, and future perspectives of MI-MVS. Methods: A review of currently available literature on MI-MVS was performed, focusing on direct-vision, video-assisted, fully endoscopic, and robotic-assisted approaches. Best practice models regarding preoperative imaging, cannulation strategies, myocardial protection, MV repair techniques, perioperative management, and Enhanced Recovery After Surgery (ERAS) protocols as well as important clinical outcome measures are discussed. Results: Minimally invasive MV surgery provides reduced surgical trauma, shorter hospitalization, lower infection rates, and a faster recovery. Video-assisted right mini-thoracotomy remains the most commonly adopted approach, whereas fully endoscopic and robotic-assisted techniques continue to expand. Routine preoperative contrast-enhanced computed tomography improves patient selection as well as procedural planning and reduces the risk of stroke. Careful patient selection and structured mentorship are essential to overcome the learning curve. Conclusions: Minimally invasive MV surgery has become an established and effective treatment strategy for MV disease in experienced centres. Ongoing advances in surgical technology, imaging tools, ERAS protocols, and robotic platforms, are expected to further expand its global adoption. Standardized training pathways, careful patient selection, and experienced institutional mentorship remain critical for optimizing clinical outcomes.

  • Open Access

    Aortic root abscess in a high-risk case requiring modified hemi-UFO procedure with custom-made pericardial conduit – a case report

    by Vanessa I. T. Zwaans, Jasper Iske, Leonard Pitts, Christoph T. Starck, Herko Grubitzsch, Jörg Kempfert, Volkmar Falk, Leonhard Wert

    Background: The UFO procedure is an established surgical technique to treat extensive endocarditis of the aortic or mitral valve with involvement of the intervalvular fibrous body (IVFB). This technique can be used for radical resection of the whole infected tissue. Independently of the size of the infected region it is unavoidable to replace both valves. In this high-risk re-do case we performed a modified so-called hemi-UFO procedure with preservation of the mitral valve. Case summary: We present a 71-year-old male patient initially diagnosed with severe stenosis of the aortic valve. An aortic valve replacement with a 23-mm prosthesis was performed via partial upper mini-sternotomy. Eight weeks after surgery an echocardiogram revealed a large vegetation and severe regurgitation of the aortic valve prosthesis. The risk of death following reintervention heart surgery (EuroSCORE II) was calculated as 50.64%. We performed a re-do with full sternotomy. Intraoperatively it was observed that the aortic prosthesis was partially torn out. The aortic annulus exhibited circular infection with an abscess connecting to the left atrium. The tissue of the left atrial roof was partially destroyed, similar to a phlegmonous infection. We opened the left atrial roof and radically resected the infected tissue up to the IVFB. We prepared a custom-made conduit prosthesis of bovine pericardium with a 25-mm valve prosthesis. We replaced two thirds of the ascending aorta with re-implantation of the coronary arteries using the Bentall-de Bono technique. We were able to stabilise and implant the new aortic valve prosthesis with sutures through the opened left atrial roof. The stitches began close to the anterior mitral leaflet region and ended in the direction of the left ventricle outflow tract. All sutures were pericardium-pledgeted and were passed through a bovine pericardial patch. This patch formed a new mitral annulus and was used for the closure of the left atrial roof. We had to reconstruct the IVFB, the roof of the left atrium and the mitral annulus in the anterior (A1), middle (A2) and posterior (A3) segments. The patient was transferred to the intensive care unit with no inotropes and in sinus rhythm. The 3-year follow-up was uneventful. Conclusion: We showed a successful surgical treatment of aortic prosthesis endocarditis with involvement of the IVFB. We were able to perform a radical resection of the infected tissue, reconstruct and replaced all sacrificed tissue with biological tissue and preserved the native mitral valve in a modified hemi-UFO procedure.

  • Transfer Learning for Multimodal Whole Heart Segmentation Supported by Intensity Transformations

    by Johanna Brosig, Lisa Bautz, Inna Khasyanova, Lars Walczak, Simon Sündermann, Jörg Kempfert, Titus Kühne, Anja Hennemuth, Markus Hüllebrand

  • Radiomics for Predicting TAVI-Related Complications: A Fully-Automatic, Interpretable Alternative to CNNs and Conventional Anatomical Measurements

    by Nina Krüger, Johanna Brosig, Ann Laube, Matthias Ivantsits, Markus Hüllebrand, Isaac Wamala, Inna Khasyanova, Jörg Kempfert, Alexander Meyer, Simon Sündermann, et al.

  • Open Access

    Total Arch Replacement with a New Hybrid Device to Manage the Left Subclavian Artery in the Frozen Elephant Trunk Technique

    by Leonard Pitts, Markus Kofler, Matteo Montagner, Jörg Kempfert

    Objectives: Total arch replacement using the frozen elephant trunk technique remains the gold standard for a definite aortic arch repair. To facilitate surgical management of the left subclavian artery (LSA), a new hybrid frozen elephant trunk device was recently developed. Methods: A 62-year-old female patient presented with acute type A aortic dissection and underwent emergent aortic root and total arch replacement using the novel custom-made Evita Neo EDE hybrid arch device for frozen elephant trunk implantation. To facilitate the management of the LSA, a covered stent connected to the device was inserted into the LSA via guidewire prior to performing the distal anastomosis in zone two. Results: Postoperative computed tomographic angiography demonstrated excellent outcome and technical success with no signs of endoleak or device-related complications. The patient was discharged home 11 days after surgery in a stable clinical condition. Conclusions: The new Neo EDE hybrid arch device for frozen elephant trunk implantation is easy to use and simplifies surgical management of the LSA without adding technical complexity.

  • Open Access

    Custodiol Versus Del Nido Cardioplegia in Minimally Invasive Mitral Valve Repair–a Propensity Score-Matched Study

    by Dustin Greve, Serdar Akansel, Jan Holler, Martina Dini, Emilija Miskinyte, Hristian Hinkov, Stephan Jacobs, Volkmar Falk, Jörg Kempfert, Markus Kofler

    Objectives: Minimally invasive mitral valve repair (MIMVR) is the preferred approach to treat mitral regurgitation in specialized centres. Custodiol and Del Nido cardioplegia are widely used, yet direct comparative data on their efficacy and safety in this setting remain limited. This study investigated their efficacy and impact on early outcomes in a propensity-matched cohort. Methods: We performed a single-centre, retrospective matched cohort study of 2490 patients undergoing minimally invasive mitral valve surgery between October 2014 and January 2025. After exclusions, 960 patients entered 1:1 propensity score matching based on risk factors, baseline characteristics and procedural parameters, yielding 778 matched cases treated with Custodiol or Del Nido cardioplegia. Perioperative dynamics of cardiac enzymes were evaluated as the primary outcome measure, along with an exploratory analysis on clinical outcomes. Results: Del Nido cardioplegia was associated with lower postoperative creatine kinase and creatine kinase‑MB levels, most pronounced in the first 24 hours (P < .001). Del Nido yielded a lower inotrope score at 6 hours, higher perioperative sodium and fewer cardioversions for ventricular arrhythmia after declamping with fewer shocks required (all P < .001). Rates of major complications were similar between groups, and 30‑day mortality was 0% in both groups. Conclusions: Del Nido cardioplegia provided superior myocardial protection based on biomarker dynamics and a lower incidence of post-cross-clamp ventricular arrhythmia, while overall clinical outcomes remained comparable. It may therefore be considered the preferred single-dose cardioplegic solution for MIMVR.

  • Open Access

    Perioperative high-dose selenium supplementation in open thoracic aortic surgery: a post hoc subgroup analysis of the SUSTAIN CSX trial

    by Daniel Catena, Christian Stoppe, Ghaith Mohsen, Lorenzo Germinario, Maren Kleine-Brueggeney, Benjamin O’BRien, Sascha Ott, Xenia Athanasia Hagen, Andrea Orsenigo, Nicolas Hellner, et al.

    Background: Open surgery on the thoracic aorta is associated with a variable and often pronounced postoperative inflammatory response, which contributes to organ injury and prolonged intensive care unit (ICU) stays. Various anti-inflammatory strategies have been proposed as a way to modulate this response and therefore improve clinical outcomes. The SUSTAIN-CSX randomized controlled trial investigated the effect of perioperative high-dose selenium supplementation on mortality and organ dysfunction in cardiac surgery patients. In this post hoc analysis, we examined its effect on 30-day mortality and organ dysfunction in patients undergoing open thoracic aortic surgery. Methods: We conducted a post hoc analysis of patients who underwent open thoracic aortic surgery within the SUSTAIN-CSX trial, a multicenter randomized controlled trial evaluating perioperative intravenous high-dose selenium supplementation in cardiac surgery. The selenium regimen consisted of 2,000 µg sodium selenite at anesthesia induction, 2,000 µg immediately postoperatively, and 1,000 µg daily for up to 10 days in the ICU. Patients treated with endovascular interventions of the thoracic aorta were excluded. Results: A total of 287 patients were included, with 144 randomized to selenium and 143 to placebo. The primary outcome, 30-day mortality, did not differ significantly between groups (selenium 2.8% vs. placebo 3.5%; P=0.73). Clinically relevant postoperative atrial fibrillation (POAF) occurred more frequently in the selenium group (selenium 18.1% vs. placebo 10.5%; P=0.03). Non-cardiac organ dysfunction, including acute kidney injury (AKI), postoperative delirium and Sequential Organ Failure Assessment (SOFA) scores, was comparable between groups. Postoperative inflammatory and organ injury markers were overall comparable, although patients receiving selenium showed a non-significant trend toward lower creatine kinase-myocardial band (CK-MB) levels (selenium 18.9 µg/L vs. placebo 28.3 µg/L; P=0.07). Six-month survival, ICU and hospital length of stay, readmission rates, and measures of functional recovery did not differ between groups. Conclusions: Perioperative intravenous high-dose selenium supplementation did not improve 30-day mortality and was associated with an increased incidence of clinically relevant POAF in this exploratory subgroup analysis. Routine selenium supplementation in this setting cannot be recommended.


  • Open Access

    A Type-Entry-Malperfusion-Based Propensity Score Matched Analysis Depending on Surgical Expertise in Patients Without Malperfusion Undergoing Surgery for Acute Type A Aortic Dissection

    by Leonard Pitts, Lina Hülsenberg, Matteo Montagner, Markus Kofler, Gaik Nersesian, Julius Kaemmel, Roland Heck, Semih Buz, Volkmar Falk, Axel Unbehaun, et al.

    Objectives: This study investigates differences in short- and mid-term outcomes in patients without malperfusion undergoing surgery for acute type A aortic dissection between specialized aortic surgeons and non-aortic surgeons. Methods: Patients who underwent surgery for acute type A aortic dissection between 2013 and 2023 defined as M0 (no malperfusion) according to the type-entry-malperfusion classification were included and divided into 2 groups according to the surgeon’s expertise: aortic surgeon vs non-aortic surgeon group, whereas an aortic surgeon was defined by expertise in extensive aortic arch surgery including frozen elephant trunk implantation on a regular basis (average ≥5/year). After propensity score matching, the groups were compared in terms of intraoperative variables and outcomes including a primary combined end-point consisting of 30-day mortality and/or CT-confirmed stroke. Results: The matched cohort comprised 2 balanced groups with 234 patients (117 in each group). Cardiopulmonary bypass, cross-clamp and distal arrest times did not differ significantly between the groups. However, more extensive aortic surgery was performed by aortic surgeons: aortic root replacement (Bentall) (P = .007; odds ratio [OR] 1.18 [CI, 1.05-1.32]), valve-sparing root replacement (David) (P = .013; OR 1.05 [CI, 1.01-1.10]), and frozen elephant trunk implantation (P < .001; OR 1.18 (CI, 1.09-1.27]). The combined end-point of 30-day mortality and/or CT-confirmed stroke was 26% in the non-aortic surgeon vs 23% in the aortic surgeon group (P = .54; OR 0.97 [CI, 0.86-1.08]). Further clinical outcomes, including 5-year survival, did not differ significantly (P = .170). Conclusions: Patients without preoperative malperfusion undergoing surgery for ATAAD show no differences in terms of short- and mid-term outcomes between specialized aortic and non-aortic surgeons. However, more extensive aortic repair may be performed safely by specialized aortic surgeons. These results support the definition of an aortic surgeon based on experience with the frozen elephant trunk technique and may advocate for call coverage by an aortic surgeon for type A repair at high-volume centres.